We did see confirmation of both occurrences in our analyses, but interestingly, once the tumor was pretreated with lenvatinib, lenvatinib seemed to block the PD-L1 upregulation levels, thus making the tumor visible for the immune system. The gene discussed is CD274; the disease is neoplasm.